Related Experiment Video
Updated: Oct 15, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
What Should the Public Know About Implantable Material and Device Innovation in the US?
1Senior consultant at Biologics Consulting in Alexandria, Virginia.
Abstract:
Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. At the macro level, designers and manufacturers of implantable devices and regulators must balance the need for assurance of devices' safety and effectiveness with industry and clinical investigational enthusiasm about innovation. At the micro level, clinician-investigators need to inform patient-subjects about a particular device's influence, for better or worse, on short- and long-term health goals.
Related Concept Videos
Bacterial Signaling
Drug Products: Biologics, Biosimilars and Interchangeables
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation

